Tag: stage III NSCLC

Patient Basics: Large Cell Cancer of the Lung

Osimertinib significantly improved progression-free survival in patients with unresectable stage III non-small cell lung cancer

byMelanie Adams, MDand1 others

June 17, 2024

1. Treatment with osimertinib significantly improved progression-free survival, compared to placebo, in patients with unresectable stage III EGFR-mutated NSCLC 2. ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result